Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial. Pottecher J, Raffi F, Jandrot-Perrus M, Binay S, et al. PLoS One 2024;19:e0302897.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pottecher J, Raffi F, Jandrot-Perrus M, Binay S, et al. Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial. PLoS One 2024;19:e0302897.
PMID: 38885234